Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Nov;98(48):e18095.
doi: 10.1097/MD.0000000000018095.

Pancreas lipiodol embolism induced acute necrotizing pancreatitis following transcatheter arterial chemoembolization for hepatocellular carcinoma: A case report and literature review

Affiliations
Review

Pancreas lipiodol embolism induced acute necrotizing pancreatitis following transcatheter arterial chemoembolization for hepatocellular carcinoma: A case report and literature review

Youwen Tan et al. Medicine (Baltimore). 2019 Nov.

Abstract

Rationale: Transcatheter arterial chemoembolization (TACE) is recognized as one of the most commonly used modalities for non-surgical treatment for advanced hepatocellular carcinoma (HCC). Ectopic lipiodol embolism is an extremely rare complication of TACE.

Patient concerns: A 61-year-old man who had a 10-year history of cirrhosis caused by hepatitis B infection was diagnosed with ascites and HCC. Subsequently, the patient underwent TACE. However, he experienced persistent left upper abdominal pain, poor appetite, nausea, moderate fever and accompanied by elevation of serum and urine amylase on the 2nd and 3nd day after treatment.

Diagnoses: The patient was diagnosed as having acute hemorrhagic necrotizing pancreatitis based on biochemical and inflammatory markers and CT findings. We deduced that the acute necrotizing pancreatitis was caused by a small branch of the left hepatic artery feeding the pancreas tail and embolizing the drug and lipiodol shunting to the tail of the pancreas.

Interventions: The patient was treated for 5 days according to the comprehensive treatment of acute necrotizing pancreatitis, by the inhibition of the secretion of pancreatic juice, relieving pain, and total parenteral nutrition and forbidding diet. The symptoms of the patient were observed to improve, and SAMS and urinary amylase (UAMS) level decreased to 143 IU/L and 254 IU/L, respectively and oral diet was permitted.

Outcome: After a period of 2 weeks, the contrast abdominal CT showed slightly decreased fluid collection of the peri-pancreatic space. Moreover, it also showed flocculous and linear high-density shadow in the pancreatic tail, suggesting lipiodol deposition in the pancreatic tail. Subsequently, the symptoms were observed to abate, and the patient left the hospital. On the 21st day after TACE, the patient had a follow up in our outpatient department; the biochemical characteristics and inflammatory markers were observed to be normal CONCLUSION:: AP is still a rare complication after TACE. Etiology is still attributed to the occurrence of shunting and embolization drug reflux. Strategies strengthening the catheter tip that is placed as close to the distal branches of the hepatic artery for the possible careful injection of embolic materials is still the key to avoid post-TACE AP.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Abdominal CT image showing the pancreatic tail pre-and post-TACE. A: Normal pancreatic tail before TACE. B: Swelling and a low-density area in the tail of the pancreas, suggesting necrosis. Dense lipiodol accumulation in the dorsal pancreatic tail after the 3rd day of TACE. C: A flocculous and linear high-density shadow also appeared in the pancreatic tail, with a slightly low-density fluid effusion and a few spots of high density after 28th day of TACE.
Figure 2
Figure 2
Liver imaging by digital subtraction angiography (DSA). A: A large lesion of HCC (black arrowhead) and pancreatic tail (white arrowhead); B: Micro catheter situated before the left hepatic artery bifurcation (white arrow). Lesion feeding artery from left hepatic artery (white arrowhead) and feeding pancreatic tail from left hepatic artery branch (black arrowhead).

References

    1. Wang Z, Li Z, Ji Y. Postoperative transcatheter arterial chemoembolization should be recommended in the hepatocellular carcinoma treatment guidelines of the American Association for the Study of Liver Diseases. Hepatology 2011;54:1489–90. - PubMed
    1. Piscaglia F, Tovoli F, Pini P, et al. A new horizon in the prevention of the postembolization syndrome after transcatheter arterial chemoembolization for hepatocellular carcinoma. Hepatology 2018;67:467–9. - PubMed
    1. Nie Q, Wu H, Guo P, et al. Cerebral lipiodol embolism following abdomen trauma in a patient with hepatocellular carcinoma treated with transcatheter arterial chemoembolization. Acta Neurolog Belgica 2015;115:459–61. - PubMed
    1. Li Z, Ni RF, Busireddy KK, et al. Cerebral lipiodol embolism following transcatheter arterial chemoembolization for hepatocellular carcinoma: a report of two cases and literature review. Chin Med J 2011;124:4355–8. - PubMed
    1. Wu L, Yang YF, Liang J, et al. Cerebral lipiodol embolism following transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2010;16:398–402. - PMC - PubMed

MeSH terms